Cargando…
Unusual paraneoplastic neurological syndrome secondary to a well differentiated pancreatic neuroendocrine tumor: a case report and review of the literature
BACKGROUND: Paraneoplastic neurological syndrome (PNS) is a heterogeneous group of disorders affecting any part of the nervous system, in a patient affected by cancer. PNS is estimated to occur in 0.01 to 8 % of cancer patients, with higher incidence in those with small cell lung cancer, gynecologic...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652398/ https://www.ncbi.nlm.nih.gov/pubmed/26582328 http://dx.doi.org/10.1186/s12885-015-1923-4 |
_version_ | 1782401745943527424 |
---|---|
author | Brizzi, Maria Pia Sonetto, Cristina Tampellini, Marco Di Maio, Massimo Volante, Marco Scagliotti, Giorgio V. |
author_facet | Brizzi, Maria Pia Sonetto, Cristina Tampellini, Marco Di Maio, Massimo Volante, Marco Scagliotti, Giorgio V. |
author_sort | Brizzi, Maria Pia |
collection | PubMed |
description | BACKGROUND: Paraneoplastic neurological syndrome (PNS) is a heterogeneous group of disorders affecting any part of the nervous system, in a patient affected by cancer. PNS is estimated to occur in 0.01 to 8 % of cancer patients, with higher incidence in those with small cell lung cancer, gynecological tumours or hematological disease. Paraneoplastic cerebellar degeneration (PCD) is the most common PNS, but it has never been reported in patients with pancreatic well-differentiated neuroendocrine tumours. CASE PRESENTATION: A 61-year-old man presented with an unusual PNS and absence of circulating neural auto-antibodies. Subsequently, contrast-enhanced computed tomography revealed a large pancreatic mass, together with multiple liver metastases, histologically diagnosed as a well-differentiated neuroendocrine tumor. Initial treatment with long-acting somatostatin analogue (octreotide LAR) and prednisone achieved a biochemical response (reduction of chromogranin A level) and a radiological disease control, but patient experienced only a brief improvement of neurological symptoms. Seven months after the onset of the symptoms, he died from neurological impairment. CONCLUSIONS: PNS can be associated with metastatic non-functioning well-differentiated pancreatic neuroendocrine tumors. These tumors may be unresponsive to treatment with somatostatin analogues and an early neurological treatment should be considered for the optimal management of these uncommon cases. |
format | Online Article Text |
id | pubmed-4652398 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46523982015-11-20 Unusual paraneoplastic neurological syndrome secondary to a well differentiated pancreatic neuroendocrine tumor: a case report and review of the literature Brizzi, Maria Pia Sonetto, Cristina Tampellini, Marco Di Maio, Massimo Volante, Marco Scagliotti, Giorgio V. BMC Cancer Case Report BACKGROUND: Paraneoplastic neurological syndrome (PNS) is a heterogeneous group of disorders affecting any part of the nervous system, in a patient affected by cancer. PNS is estimated to occur in 0.01 to 8 % of cancer patients, with higher incidence in those with small cell lung cancer, gynecological tumours or hematological disease. Paraneoplastic cerebellar degeneration (PCD) is the most common PNS, but it has never been reported in patients with pancreatic well-differentiated neuroendocrine tumours. CASE PRESENTATION: A 61-year-old man presented with an unusual PNS and absence of circulating neural auto-antibodies. Subsequently, contrast-enhanced computed tomography revealed a large pancreatic mass, together with multiple liver metastases, histologically diagnosed as a well-differentiated neuroendocrine tumor. Initial treatment with long-acting somatostatin analogue (octreotide LAR) and prednisone achieved a biochemical response (reduction of chromogranin A level) and a radiological disease control, but patient experienced only a brief improvement of neurological symptoms. Seven months after the onset of the symptoms, he died from neurological impairment. CONCLUSIONS: PNS can be associated with metastatic non-functioning well-differentiated pancreatic neuroendocrine tumors. These tumors may be unresponsive to treatment with somatostatin analogues and an early neurological treatment should be considered for the optimal management of these uncommon cases. BioMed Central 2015-11-18 /pmc/articles/PMC4652398/ /pubmed/26582328 http://dx.doi.org/10.1186/s12885-015-1923-4 Text en © Brizzi et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Case Report Brizzi, Maria Pia Sonetto, Cristina Tampellini, Marco Di Maio, Massimo Volante, Marco Scagliotti, Giorgio V. Unusual paraneoplastic neurological syndrome secondary to a well differentiated pancreatic neuroendocrine tumor: a case report and review of the literature |
title | Unusual paraneoplastic neurological syndrome secondary to a well differentiated pancreatic neuroendocrine tumor: a case report and review of the literature |
title_full | Unusual paraneoplastic neurological syndrome secondary to a well differentiated pancreatic neuroendocrine tumor: a case report and review of the literature |
title_fullStr | Unusual paraneoplastic neurological syndrome secondary to a well differentiated pancreatic neuroendocrine tumor: a case report and review of the literature |
title_full_unstemmed | Unusual paraneoplastic neurological syndrome secondary to a well differentiated pancreatic neuroendocrine tumor: a case report and review of the literature |
title_short | Unusual paraneoplastic neurological syndrome secondary to a well differentiated pancreatic neuroendocrine tumor: a case report and review of the literature |
title_sort | unusual paraneoplastic neurological syndrome secondary to a well differentiated pancreatic neuroendocrine tumor: a case report and review of the literature |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652398/ https://www.ncbi.nlm.nih.gov/pubmed/26582328 http://dx.doi.org/10.1186/s12885-015-1923-4 |
work_keys_str_mv | AT brizzimariapia unusualparaneoplasticneurologicalsyndromesecondarytoawelldifferentiatedpancreaticneuroendocrinetumoracasereportandreviewoftheliterature AT sonettocristina unusualparaneoplasticneurologicalsyndromesecondarytoawelldifferentiatedpancreaticneuroendocrinetumoracasereportandreviewoftheliterature AT tampellinimarco unusualparaneoplasticneurologicalsyndromesecondarytoawelldifferentiatedpancreaticneuroendocrinetumoracasereportandreviewoftheliterature AT dimaiomassimo unusualparaneoplasticneurologicalsyndromesecondarytoawelldifferentiatedpancreaticneuroendocrinetumoracasereportandreviewoftheliterature AT volantemarco unusualparaneoplasticneurologicalsyndromesecondarytoawelldifferentiatedpancreaticneuroendocrinetumoracasereportandreviewoftheliterature AT scagliottigiorgiov unusualparaneoplasticneurologicalsyndromesecondarytoawelldifferentiatedpancreaticneuroendocrinetumoracasereportandreviewoftheliterature |